News
-
-
-
PRESS RELEASE
Sirtex Medical's DOORwaY90 Study Demonstrates 100% Local Tumor Control with SIR-Spheres®, Setting a New Benchmark in Y-90 for HCC
Sirtex Medical's DOORwaY90 Study shows exceptional 100% local tumor control with SIR-Spheres®, setting new Y-90 benchmark for HCC. Results presented at SIR Annual Meeting